Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 182 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1811 ? Recurrent GBM 5 Chemotherapy
Radiation
University of Rochester School of Medicine and Dentistry United States 4/2003
Treatment Details: Patients: This Phase I study involved a total of 29 patients with recurrent malignant gliomas. Nineteen patients had glioblastoma multiforme, 3 had gliosarcoma, 5 had anaplastic astrocytoma
 
1812 ? Stage T3 rectal cancer 3 Chemotherapy
Radiation
Surgery
Stanford University Medical Center United States 1/2003
Treatment Details: Patients: Thirty-two patients (21 men, 11 women) with biopsy-proven adenocarcinoma of the rectum were enrolled in this Phase II study. All patients were staged at T3. Treatment: Treatmen
 
1813 ? Newly diagnosed rectal cancer 3 Chemotherapy
Radiation
Martin-Luther-Universitat Germany 10/2002
Treatment Details: Patients: This Phase I study involved 36 patients. 92% of patients had newly diagnosed rectal cancer. Treatment: Treatment consisted of concurrent radiotherapy and the chemotherapy drug
 
1814 ? Locally advanced rectal cancer 4 Radiation
Surgery
University Hospital of Geneva Switzerland 11/2002
Treatment Details: Patients: This Phase I-II study involved 50 patients with locally advanced rectal cancer. Forty-five patients had T3 tumors and four had T4 tumors. Nodal involvement was documented in 26
 
1815 ? Locally advanced rectal cancer 4 Chemotherapy
Radiation
Surgery
Lyon Sud Pierre Benite France 3/2003
Treatment Details: Patients: Forty patients with locally advanced rectal cancer were involved in this Phase II study. Treatment: Treatment consisted of the combination of radiation, fluorouracil (adrucil),
 
1816 ? Dukes B or C colorectal cancer 2 Chemotherapy
Surgery
Aichi Cancer Center Hospital Japan 2/2002
Treatment Details: Patients: This trial involved 289 patients (“full-analysis set”) with Dukes B or C colorectal cancer. Patients were divided into two groups: UFT group and Control group. The UFT group con
 
1817 ? Resected Dukes C colon cancer 5 Chemotherapy
Vienna University Medical School Austria 12/2003
Treatment Details: Patients: This Phase II study involved 1,967 patients with resected Dukes' C colon carcinoma. Patients were divided into two groups: Group 1 comprised 993 patients and Group 2 comprised 974
 
1818 ? Locally advanced or unresectable colorectal cancer 4 Chemotherapy
Radiation
Surgery
Duke University Medical Center United States 3/2004
Treatment Details: Patients: This Phase I study involved 21 patients with locally advanced or unresectable adenocarcinoma of the rectum and colon. Treatment: Treatment consisted of the chemotherapy drugs
 
1819 ? Rectal cancer 4 Chemotherapy
Centre Hospitalier Lyon-Sud France 5/2001
Treatment Details: Patients: This Phase I study involved 17 rectal adenocarcinoma patients. Patients had T4 rectal carcinoma, T1-T3 disease with colostomy refusal, or potentially operable T2/T3 M1 requiring lo
 
1820 ? Rectal cancer (Duke stages A-C) Surgery
University of Rome Italy 2/2001
Treatment Details: Patients: Fifty-three patients with rectal carcinoma were part of this study (Dukes stages A-C). Treatment: Treatment consisted of low anterior resection and total mesorectal excision (
 
Page 182 of 187  | Previous Page  | Next Page